By Doug Macron
Rosetta Genomics said last week that it is working to out-license a portion of its microRNA intellectual property and technology in the field of oncology in an effort to raise funds so that it can focus on its core areas of interest.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.
GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.
Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.
A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.